LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...

A project that implemented targeted screening for candida auris in ventilator-assisted healthcare facilities has found relatively high rates of colonization in nursing homes, and evidence that testing ...

Please provide your email address to receive an email when new articles are posted on . “However, we did not have much data about whether and how hospitals across the country were conducting C. auris ...

T2 Biosystems Inc. received a third FDA breakthrough device designation with its direct-from-blood molecular diagnostic test for Candida auris. The test joins its T2resistance panel and T2Lyme panel ...

Findings published in the special Clinical Chemistry issue, "Genomics: Current & emerging trends in the clinical laboratory" Altogether, this means that healthcare professionals might waste precious ...

T2 Biosystems (NASDAQ:TTOO) has received breakthrough device status from the US Food and Drug Administration for its Candida auris molecular diagnostic blood test. The test is designed to detect C.

Medical device maker T2 Biosystems (NASDAQ:TTOO) has submitted an application to the US Food and Drug Administration for breakthrough device designation for its detection test for the emerging ...

“An inpatient has tested positive for C. auris, an emerging pathogen that is spreading in the U.S.,” a spokesperson for WVU Medicine said in a statement to local news outlets. “We are working with the ...

It was first identified in 2009 in Japan. But the Center for Disease Control and Prevention only recently deemed the fungus an “urgent threat” in the US. Why? It's been spreading rapidly through ...

A drug-resistant fungus found in medical facilities spread at an "alarming rate" from 2020 to 2021, the US Centers for Disease Control and Prevention said on Monday. While the fungus, Candida auris, ...

LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that ...